Business
Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing
CHONGQING, China, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) today announced that it has attended the official opening of Porton Pharma
About this update from Codexis, Inc.
[{"type":"text","content":"CHONGQING, China, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) today announced that it has attended the official opening of Porton Pharma Solutions Ltd.’s (SZSE: 300363) fermentation pilot laboratory located in Porton’s Changshou site, achieving another important milestone in the strategic partnership between Porton and Codexis in the field of biocatalysis technology.\n The opening of Porton’s biocatalysis technology lab and fermentation facility at its Changshou site in Chongqing builds on its previous strategic investments in biocatalysis, and its partnership with Codexis. In 2018, in order to further expand the value adding application of biocatalysis in pharmaceutical processes, Porton and Codexis announced their strategic partnership, and Porton established licensed biocatalysis capabilities at its Shanghai R&D center. Since then, the partnership has focused on screening biocatalysts against many of Porton’s CDMO process opportunities. Porton’s new biocatalysis infrastructure in Chongqing adds enzyme development and pilot scale manufacturing to its established high throughput biocatalysis screening expertise. These investments enable the prospect to broaden the application of Codexis’ biocatalyst technologies within Porton’s global pharmaceutical customer base. \"Codexis is the leader in protein engineering technology, while Porton is a Contract Development and Manufacturing Organization (CDMO) that serves more than 300 projects annually,” said Oliver Ju, Chairman and CEO of Porton, “The collaboration between Porton and Codexis during the past 18 months has achieved a win-win situation for not only us, but also for our customers. I look forward to continuing to provide advanced, green, and sustainable technology for customers around the world through in-depth cooperation with Codexis, and to pushing our strategic cooperation to a broader application space.\" \"It is my great honor to witness the launch of Porton's pilot fermentation laboratory in Chongqing. Since Codexis and Porton cemented our strategic cooperation in April 2018, we have been maintaining a close and productive collaboration in the application of biocatalysis technology,” said Pierre Brazeau, Codexis’ VP of Business Development. John Nicols, Codexis’ President and CEO, added “We are excited to support Porton in expanding the partnership an...